Kangji Medical IPO: Valuation Insights
Kangji Medical (1498779D CH) is the largest domestic minimally invasive surgical instruments and accessories (MISIA) platform in China, with a 2.7%...
353 Views
Venus Medtech Lock-Up Expiry: Could Face Selling Pressure
Venus Medtech is a dominant player in the heart valve replacement (TAVR) market in China and was listed in Hong Kong on December 10th. Since...
408 Views
Kangji Medical (康基医疗) Pre-IPO: COVID-19 Impacts and Thoughts on Valuation
Kangji Medical is a domestic leader in minimally invasive surgery devices. It has three main product types, trocars, polymer ligation clips, and...
504 Views
HKEx (388.HK): Trading Volume in May Points to Upside and New License Agreement with MSCI
HKEX (388 HK) just released its May market statistics. The May month ADT (Average Daily Turnover) has registered 14% month-to-month rebound to HKD...
403 Views
ECM Weekly (17 May 2020) -Dada Nexus, Kintor Pharma, Yeahka, Archosaur Games
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming...
193 Views